image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
Filing Date
July 11, 2016
Document Date
July 11, 2016
Filing Group
Other
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC